World's Fist-of-its-Kind Drug Delivery Device Launched for Precise Dosing of Cannabis
In Israel, Syqe Medical has launched the world's first metered-dose cannabis inhaler that meets pharmaceutical standards.
After eight years of extensive research and development, including rigorous testing in multiple clinical trials, Syqe Medical has paved the way for a groundbreaking regulatory pathway.
This milestone signifies a new era in pain treatment, where physicians can confidently prescribe precise doses of cannabis for their patients.
The Syqe Inhaler addresses concerns regarding dosage accuracy, minimizing uncertainties in administration and mitigating potential adverse events and psychoactive effects.
This innovative device has obtained regulatory approval from the Israeli Ministry of Health, making it the first of its kind to receive such authorization. It will be exclusively available to licensed patients within the Israeli market.
By offering complex respiratory technique automation, electronic selective dosing, remote clinical monitoring, and dose control, the inhaler enables healthcare professionals to embrace medical cannabis with greater confidence. Additionally, it enhances the practicality of cannabis application.
The distribution and marketing of Syqe's cannabis inhaler will be carried out by Teva Israel, ensuring that the device is produced under strict pharmaceutical conditions adhering to Good Manufacturing Practices (GMP).
.
